Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial - Gregorio, Amelie de; Häberle, Lothar; Fasching, Peter A.; Müller, Volkmar; Schrader, Iris; Lorenz, Ralf; Forstbauer, Helmut; Friedl, Thomas W. P.; Bauer, Emanuel; Gregorio, Nikolaus de; Deniz, Miriam; Fink, Visnja; et al. (Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022)